← All companies

QNTM

Quantum BioPharma Ltd.

QNTM Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.05

+0.21 +7.39%

Key statistics

from XBRL data in SEC filings

Market cap

$36.6

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.07 – $31.91

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K May 18, 2026 6-K FORM 6-K May 7, 2026 6-K FORM 6-K May 6, 2026 6-K FORM 6-K Apr 22, 2026 6-K FORM 6-K Apr 2, 2026 6-K FORM 6-K Apr 1, 2026 6-K FORM 6-K Mar 30, 2026 6-K FORM 6-K Mar 27, 2026 20-F FORM 20-F Mar 26, 2026 6-K FORM 6-K Mar 26, 2026 6-K FORM 6-K Mar 23, 2026 6-K FORM 6-K Dec 23, 2025 6-K Dec 22, 2025 6-K FORM 6-K Dec 22, 2025 6-K FORM 6-K Dec 22, 2025 6-K/A Dec 11, 2025 6-K Dec 8, 2025 6-K FORM 6-K Dec 1, 2025 6-K FORM 6-K Nov 28, 2025 6-K FORM 6-K Nov 26, 2025 6-K FORM 6-K Nov 25, 2025 6-K FORM 6-K Nov 7, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 29, 2025 6-K FORM 6-K Oct 29, 2025 6-K FORM 6-K Oct 29, 2025 6-K/A FORM 6-K/A Oct 28, 2025 6-K/A FORM 6-K/A Oct 28, 2025 6-K FORM 6-K Oct 23, 2025 6-K FORM 6-K Oct 20, 2025 6-K FORM 6-K Oct 14, 2025 6-K FORM 6-K Oct 8, 2025 6-K FORM 6-K Oct 3, 2025 6-K FORM 6-K Oct 2, 2025 6-K FORM 6-K Oct 1, 2025 6-K FORM 6-K Sep 29, 2025 6-K FORM 6-K Sep 24, 2025